Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. It operates in two segments, Banking and Diagnostics. The Banking segment collects, processes, banks, and tests biological materials, such as cord blood, lining, and tissue samples. The Diagnostics segment offers diagnostic testing services, such as newborn genetic and metabolic screenings; pediatric vision and ear screenings; pediatric allergen test; and genetic talent test services. The company also provides corneal lenticule banking, and lifestyle genetic screening services for adults. In addition, it offers life sprouts, medical laboratory, marketing, and property investment services, as well as medical and pharmaceutical research and development and consulting services. Cordlife Group Limited was incorporated in 2001 and is based in Singapore.
Часто задаваемые вопросы
В каком секторе работает Cordlife Group Limited (CLIFF)?
Cordlife Group Limited относится к сектору Здравоохранение.
Какова текущая цена акций Cordlife Group Limited (CLIFF)?
По последним данным, цена акций Cordlife Group Limited составляет 0,13 $, предыдущее закрытие — 0,13 $.
Выплачивает ли Cordlife Group Limited (CLIFF) дивиденды?
Нет, Cordlife Group Limited не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у Cordlife Group Limited (CLIFF)?
У компании Cordlife Group Limited бета 0.666, что указывает на более низкую волатильность по сравнению с рынком в целом.
